Understanding the Evolving Immuno-Oncology Treatment Paradigm in Non-Small-Cell Lung Cancer

Explore the recent expansion of new data new indications and new immunotherapies in the treatment of NSCLC with this comprehensive educational program featuring an on-demand webcast and downloadable slides from a live CCO webinar as well as an FAQ podcast and expert-authored commentary highlighting new data from WCLC Virtual 2021.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Bristol Myers Squibb

Genentech, a member of the Roche Group

Helsinn Healthcare SA

Merck Sharp & Dohme Corp.